Company: ZLAB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023411
Chunk: 28

Company: Zai Lab Ltd
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 28
---
Item 1. Financial Statements.

Zai Lab Limited 

Unaudited Condensed Consolidated Balance Sheets 

(in thousands of U.S. dollars (“$”), except for number of shares and per share data) 

NotesMarch 31,2025December 31,2024AssetsCurrent assetsCash and cash equivalents3757,263 449,667 Restricted cash, current100,000 100,000 Short-term investments— 330,000 Accounts receivable (net of allowance for credit losses of $22 and $25 as of March 31, 2025 and December 31, 2024, respectively)76,555 85,178 Notes receivable11,118 4,233 Inventories, net453,054 39,875 Prepayments and other current assets43,878 41,527 Total current assets1,041,868 1,050,480 Restricted cash, non-current1,113 1,114 Property and equipment, net549,654 47,961 Operating lease right-of-use assets19,081 21,496 Land use rights, net2,882 2,907 Intangible assets, net656,198 56,027 Other non-current assets2,534 5,768 Total assets1,173,330 1,185,753 Liabilities and shareholders’ equity  Current liabilities  Accounts payable103,017 100,906 Current operating lease liabilities6,574 8,048 Short-term debt10173,405 131,711 Other current liabilities1136,811 58,720 Total current liabilities319,807 299,385 Deferred income30,126 31,433 Non-current operating lease liabilities12,319 13,712 Other non-current liabilities325 325 Total liabilities362,577 344,855 Commitments and contingencies (Note 17)  Shareholders’ equity  Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized; 1,089,076,400 and 1,082,614,740 shares issued as of March 31, 2025 and December 31, 2024, respectively; 1,084,164,200 and 1,077,702,540 shares outstanding as of March 31, 2025 and December 31, 2024,